ReviewOcular oncology and pathology2025
Ultrasound Biomicroscopy in the Diagnosis and Management of Iris and Ciliary Body Tumors: A Comprehensive Review.
Review in Ocular oncology and pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although uncommon, tumors of the iris and ciliary body present significant diagnostic challenges because of their variable appearance and overlap between benign and malignant features and the difficulty of directly visualizing lesions located in the posterior iris or ciliary body using conventional methods. Summary: The advent of high-resolution anterior segment imaging, particularly ultrasound biomicroscopy (UBM), has greatly enhanced the ability of clinicians to evaluate these lesions in vivo. This review synthesizes current evidence on the utility of UBM in the diagnosis, classification, and management of both iris and ciliary body tumors. The emphasis is placed on differentiating melanotic from amelanotic lesions, recognizing imaging characteristics that suggest malignancy and comparing UBM with other anterior segment modalities, such as gonioscopy and anterior segment optical coherence tomography. This study provides a detailed discussion of tumor morphology, growth patterns, and secondary complications, supplemented by illustrative examples from clinical practice. Key Message: UBM serves as a noninvasive, reproducible, and dynamic view of lesions located deep within the anterior segment, particularly those obscured from direct examination, thereby guiding both diagnosis and longitudinal management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.